Skip to main content

Life Sciences

Identifying Which Data To Review During A Clinical Data Review

In my last blog post, I presented some thoughts on showing data changed since last review. Today, we will concentrate on the level of scrutiny and what happens when recording the user actions in the review.

Not all data may require the same level of scrutiny during a review. Additional focus may need to be placed on certain critical measures. For these critical measures, it may be necessary to establish additional value added data or visualizations/aids to support the desired level of scrutiny.

The post entitled 4 Ways You Can Improve The Clinical Data Review Process provides a few examples of visualizations that can help pinpoint outliers.

If you are interested in learning how Perficient can help improve your clinical data review process, please send us an email or fill out the “contact us” form in the footer of this page.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Jim Richards

More from this Author

Follow Us